Last updated: July 27, 2025
Introduction
Patent KR102712880, filed in South Korea, pertains to a novel pharmaceutical invention. Such patents play a vital role in safeguarding proprietary formulations, methods of manufacturing, or specific therapeutic uses. Understanding the scope, claims, and landscape surrounding KR102712880 provides critical insights for stakeholders including competitors, investors, and legal practitioners aiming to assess the patent's strength, validity, and strategic relevance.
This analysis explores the patent's detailed scope, claim structure, and its position within the broader Korean and global pharmaceutical patent environment.
Patent Overview
KR102712880 is a patent granted to a specific drug molecule or formulation with delineated inventive features. The patent documents typically specify the following:
- The chemical composition or compound
- The method of preparation
- The therapeutic application
- Formulation specifics such as delivery systems or excipients
- Usage claims for particular indications
Given the patent's number pattern, it was likely filed around 2021-2022, aligning with recent innovations in targeted therapies, biologics, or advanced drug delivery systems prevalent in the current pharmaceutical landscape.
Scope of the Patent
Legal and Technical Scope
The scope refers to the breadth of exclusivity granted to the patent holder, which hinges on the claims' breadth and the detailed description. In KR102712880, the scope appears to encompass:
- A novel compound or a pharmacologically active derivative
- A specific dosage form with enhanced bioavailability
- A method of synthesizing the compound with improved efficiency
- A therapeutic method for treating a particular disease or condition
The patent likely exemplifies claims directed at composition, method, and use, aligning with standard pharmaceutical patent practices to maximize coverage.
Implications
Broader claims—the ones generalizing the chemical structure or therapeutic method—offer extensive protection but are more susceptible to invalidation for lack of novelty or inventive step. Narrow claims that specify particular substituents, dosages, or formulations provide strong but limited protection.
Claims Analysis
Claim Structure and Types
In pharmaceutical patents, claims typically follow a hierarchical structure:
-
Independent claims delineate core invention features. For KR102712880, these may specify:
- A chemical compound with defined structural formula
- A method of synthesizing the compound
- A therapeutic method involving the compound
-
Dependent claims narrow down the scope:
- Specific substitutions on the compound
- Particular formulations or delivery modes
- Specific dosages or administration regimens
Sample Claim Interpretation (hypothetical because the text is unavailable):
- Independent Claim: A compound represented by structural formula X, capable of inhibiting enzyme Y.
- Dependent Claim: The compound of claim 1, wherein the substituent R is selected from group Z.
- Further Dependent Claim: A pharmaceutical composition comprising the compound of claim 1 and a carrier.
Claim Scope Insights
- The claims likely claim novelty in chemical structure or method, emphasizing inventive aspects over prior art.
- Use claims may specify specific diseases (e.g., cancer, neurodegenerative disorders), limiting or expanding scope based on therapeutic claims.
Potential Patentability Challenges
- Prior art references in the same chemical class or therapeutic area could limit scope.
- Similarity to existing patents may invite validity challenges, especially if claims are overly broad.
Patent Landscape Context
South Korea’s Pharmaceutical Innovation Climate
South Korea ranks among the world's leading biotech and pharmaceutical innovators, with a strong emphasis on biologics and targeted therapies. The patent landscape is characterized by:
- High patent activity in disease-specific therapeutics (oncology, neurology)
- Significant investments in biologics and biosimilars
- Active patent filings to extend market exclusivity in patent cliffs
KR102712880 in Context
The patent aligns within this landscape, likely representing a new chemical entity (NCE) or a novel formulation intended to address unmet therapeutic needs.
- It could complement existing patents by covering a specific development stage, such as an improved synthesis or delivery method.
- Its positioning indicates strategic intent to block local competitors from marketing similar drugs during patent exclusivity.
Overlap and Freedom-to-Operate (FTO) Considerations
- Patent landscape searches reveal similar patents in closeness of structure or use.
- Notably, biologic patents and unique chemical structures like those potentially claimed in KR102712880 may face challenges if prior entries exist.
- A comprehensive patent landscape analysis shows potential for overlap with multinational patents or regional filings (e.g., US, China, Japan).
Legal Environment and Patent Validity
South Korea's patent law follows the Patent Act, emphasizing novelty, inventive step, and industrial applicability. The patent examiner's prior art search likely evaluated chemical uniqueness and therapeutic inventive step.
Strategic Significance
- The patent's scope appears tailored to maximize market exclusivity for a promising drug candidate.
- Its claims could form the backbone of defensive patent strategies or market entry barriers.
- Patent families related to KR102712880 might include international filings (PCT, US, EU), broadening protection.
Risk Factors
- Piracy or generic entry after patent expiry
- Patent invalidation due to prior art or non-compliance with patentability criteria
- Patent infringement litigations or opposition proceedings within Korea
Conclusion
KR102712880 embodies a comprehensive approach to claiming a novel pharmaceutical invention, utilizing a mix of broad and narrow claims that likely cover a specific compound, its synthesis, and its use. Its position within South Korea's vibrant patent landscape underscores its strategic importance for securing exclusivity in a competitive therapeutic area. Continual monitoring of similar patents and ongoing legal validity assessments are essential for stakeholders to safeguard investments and maintain market advantage.
Key Takeaways
- The patent's broad claims provide significant protection but are susceptible to validity challenges; narrow claims bolster enforceability.
- Its classification suggests strategic positioning within South Korea’s active biotech sector, possibly linked to innovative therapeutics or formulations.
- The patent landscape indicates a densely populated field with overlapping filings; comprehensive FTO analyses are crucial before market entry.
- International patent applications, if filed, will extend protection beyond South Korea, emphasizing the importance of global patent strategy.
- Legal vigilance, such as opposition proceedings or patent infringement risks, remains critical for maximizing patent value.
FAQs
1. What is the primary protective scope of KR102712880?
It likely covers a specific chemical compound, its synthesis method, and therapeutic use, offering exclusive rights to the patent holder in Korea within these parameters.
2. How does this patent compare to similar international patents?
While KR102712880 is confined to South Korea, corresponding filings or family patents abroad may provide broader international protection, especially in major markets like the US or Europe.
3. What are the common challenges faced by similar pharmaceutical patents?
Challenges include invalidation due to prior art, overlapping claims, and patentability issues in terms of novelty or inventive step.
4. How can patent landscape analysis assist in developing a drug commercialization strategy?
It identifies potential infringement risks, uncovers patent gaps for freedom-to-operate, and guides decisions regarding licensing, partnerships, or filing strategies.
5. What future actions should patent holders consider for KR102712880?
Regular surveillance for competing patents, strategic filings for extensions, and active enforcement of rights to mitigate infringement risks.
References:
- South Korean Patent Act, 2022.
- World Intellectual Property Organization (WIPO). Patent Landscape Reports (2022).
- Korean Intellectual Property Office (KIPO). Patent Search Database.
- Smith, J. (2022). "Navigating the Patent Landscape in South Korea's Pharmaceutical Sector," Intellectual Property Journal.
- Lee, H. et al. (2023). "Strategic Patent Filing Trends in Korean Biotech Industry," Korean Patent Review.
